Reuters logo
BRIEF-Uniqure publishes data further demonstrating favorable immunogenicity profile of aav5-based gene therapies
June 15, 2017 / 11:21 AM / 3 months ago

BRIEF-Uniqure publishes data further demonstrating favorable immunogenicity profile of aav5-based gene therapies

June 15 (Reuters) - Uniqure Nv

* Uniqure publishes data further demonstrating favorable immunogenicity profile and broad utilization of aav5-based gene therapies

* Uniqure NV - in study, 2 different proteins have been shown to be effectively produced in nhp liver after sequential administration of doses of aav5, aav1 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below